 Jeffrey Sankoff
Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Emergency Service, Hospital | 11 | 2020 | 1864 | 0.770 |
Why?
| | Heat Exhaustion | 1 | 2015 | 2 | 0.520 |
Why?
| | Substance Withdrawal Syndrome | 2 | 2018 | 157 | 0.500 |
Why?
| | Heat Stress Disorders | 1 | 2015 | 61 | 0.480 |
Why?
| | Respiration, Artificial | 5 | 2019 | 545 | 0.480 |
Why?
| | Clinical Protocols | 2 | 2019 | 238 | 0.430 |
Why?
| | Systemic Inflammatory Response Syndrome | 2 | 2014 | 75 | 0.420 |
Why?
| | Safety-net Providers | 1 | 2012 | 96 | 0.390 |
Why?
| | Alcohol-Related Disorders | 1 | 2012 | 111 | 0.390 |
Why?
| | Insurance Coverage | 1 | 2012 | 208 | 0.370 |
Why?
| | Insurance, Health | 1 | 2012 | 244 | 0.360 |
Why?
| | Phenobarbital | 2 | 2019 | 18 | 0.330 |
Why?
| | Methemoglobinemia | 1 | 2008 | 13 | 0.320 |
Why?
| | Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2008 | 37 | 0.320 |
Why?
| | Patient Care Team | 1 | 2012 | 521 | 0.310 |
Why?
| | Benzodiazepines | 2 | 2019 | 122 | 0.310 |
Why?
| | Health Status Indicators | 1 | 2008 | 154 | 0.300 |
Why?
| | Antimicrobial Stewardship | 2 | 2020 | 95 | 0.300 |
Why?
| | Ventilators, Mechanical | 2 | 2017 | 47 | 0.290 |
Why?
| | Dyspnea | 1 | 2008 | 201 | 0.290 |
Why?
| | Anti-Infective Agents | 1 | 2008 | 227 | 0.260 |
Why?
| | Intensive Care Units | 4 | 2017 | 635 | 0.230 |
Why?
| | Respiratory Insufficiency | 2 | 2016 | 290 | 0.220 |
Why?
| | HIV Infections | 2 | 2012 | 2459 | 0.180 |
Why?
| | Emergency Medicine | 2 | 2013 | 238 | 0.180 |
Why?
| | Alcohol Withdrawal Delirium | 1 | 2019 | 8 | 0.170 |
Why?
| | Public Health | 2 | 2013 | 450 | 0.170 |
Why?
| | Firearms | 2 | 2013 | 281 | 0.160 |
Why?
| | Smartphone | 1 | 2018 | 67 | 0.160 |
Why?
| | Length of Stay | 4 | 2019 | 1032 | 0.160 |
Why?
| | Blood Gas Analysis | 1 | 2017 | 69 | 0.150 |
Why?
| | Respiration Disorders | 1 | 2017 | 66 | 0.150 |
Why?
| | Haplotypes | 2 | 2008 | 473 | 0.140 |
Why?
| | Equipment Safety | 1 | 2016 | 38 | 0.140 |
Why?
| | Cardiac Output | 1 | 2016 | 147 | 0.140 |
Why?
| | Ambulatory Care | 1 | 2020 | 482 | 0.140 |
Why?
| | Mobile Applications | 1 | 2018 | 147 | 0.140 |
Why?
| | Hospitals, Urban | 2 | 2014 | 129 | 0.130 |
Why?
| | Fluid Therapy | 1 | 2016 | 130 | 0.130 |
Why?
| | Anti-Bacterial Agents | 2 | 2020 | 1510 | 0.110 |
Why?
| | Climate Change | 1 | 2015 | 150 | 0.110 |
Why?
| | Hot Temperature | 1 | 2015 | 334 | 0.110 |
Why?
| | Hospital Mortality | 3 | 2017 | 814 | 0.110 |
Why?
| | Adult | 10 | 2019 | 31512 | 0.110 |
Why?
| | Middle Aged | 10 | 2019 | 27617 | 0.110 |
Why?
| | Medical Assistance | 1 | 2012 | 15 | 0.110 |
Why?
| | Humans | 20 | 2020 | 118972 | 0.110 |
Why?
| | Lactic Acid | 2 | 2016 | 282 | 0.100 |
Why?
| | Alcoholism | 1 | 2018 | 717 | 0.100 |
Why?
| | Inservice Training | 1 | 2012 | 106 | 0.100 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1200 | 0.100 |
Why?
| | Sepsis | 1 | 2016 | 531 | 0.090 |
Why?
| | Interprofessional Relations | 1 | 2012 | 261 | 0.090 |
Why?
| | Critical Illness | 1 | 2014 | 662 | 0.080 |
Why?
| | Female | 11 | 2019 | 61564 | 0.080 |
Why?
| | Urokinase-Type Plasminogen Activator | 1 | 2007 | 30 | 0.080 |
Why?
| | Socioeconomic Factors | 1 | 2012 | 1129 | 0.080 |
Why?
| | Terminology as Topic | 1 | 2008 | 211 | 0.080 |
Why?
| | Quality of Health Care | 1 | 2012 | 586 | 0.080 |
Why?
| | Aged | 7 | 2019 | 19657 | 0.080 |
Why?
| | Clinical Trials as Topic | 1 | 2012 | 969 | 0.080 |
Why?
| | Prospective Studies | 5 | 2017 | 6471 | 0.070 |
Why?
| | Male | 10 | 2019 | 57801 | 0.070 |
Why?
| | Superoxide Dismutase | 1 | 2008 | 339 | 0.070 |
Why?
| | Colorado | 4 | 2019 | 4196 | 0.070 |
Why?
| | Drug Therapy, Combination | 2 | 2019 | 965 | 0.070 |
Why?
| | Acute Lung Injury | 1 | 2008 | 310 | 0.060 |
Why?
| | Mass Screening | 1 | 2012 | 1052 | 0.060 |
Why?
| | Polymorphism, Genetic | 1 | 2007 | 642 | 0.060 |
Why?
| | Diagnosis, Differential | 1 | 2008 | 1384 | 0.060 |
Why?
| | Survival Rate | 1 | 2008 | 1720 | 0.060 |
Why?
| | Sensitivity and Specificity | 1 | 2008 | 1795 | 0.060 |
Why?
| | Reproducibility of Results | 1 | 2008 | 2874 | 0.050 |
Why?
| | Inappropriate Prescribing | 1 | 2020 | 51 | 0.040 |
Why?
| | Hospitals, Teaching | 1 | 2018 | 104 | 0.040 |
Why?
| | Drug Prescriptions | 1 | 2020 | 248 | 0.040 |
Why?
| | Cohort Studies | 1 | 2008 | 5116 | 0.040 |
Why?
| | Hypercapnia | 1 | 2017 | 50 | 0.040 |
Why?
| | Hyperoxia | 1 | 2017 | 97 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2017 | 6561 | 0.040 |
Why?
| | Tidal Volume | 1 | 2016 | 74 | 0.030 |
Why?
| | Linear Models | 1 | 2018 | 827 | 0.030 |
Why?
| | Decision Support Systems, Clinical | 1 | 2018 | 178 | 0.030 |
Why?
| | Multicenter Studies as Topic | 1 | 2016 | 253 | 0.030 |
Why?
| | Patient Transfer | 1 | 2017 | 143 | 0.030 |
Why?
| | Shock, Septic | 1 | 2016 | 187 | 0.030 |
Why?
| | Equipment Design | 1 | 2016 | 519 | 0.030 |
Why?
| | Monitoring, Physiologic | 1 | 2016 | 271 | 0.030 |
Why?
| | Leukocyte Count | 1 | 2014 | 305 | 0.030 |
Why?
| | Stroke Volume | 1 | 2016 | 512 | 0.030 |
Why?
| | Attention | 1 | 2016 | 408 | 0.030 |
Why?
| | Triage | 1 | 2014 | 203 | 0.030 |
Why?
| | Hypoxia | 1 | 2017 | 963 | 0.020 |
Why?
| | Case-Control Studies | 2 | 2008 | 3171 | 0.020 |
Why?
| | Wounds, Gunshot | 1 | 2013 | 176 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2019 | 12978 | 0.020 |
Why?
| | Mandatory Reporting | 1 | 2008 | 47 | 0.020 |
Why?
| | Linkage Disequilibrium | 1 | 2008 | 273 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 4708 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 4552 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2016 | 4596 | 0.020 |
Why?
| | Europe | 1 | 2007 | 356 | 0.020 |
Why?
| | Guidelines as Topic | 1 | 2008 | 262 | 0.020 |
Why?
| | Time Factors | 1 | 2017 | 6412 | 0.020 |
Why?
| | Genome, Human | 1 | 2008 | 387 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 982 | 0.020 |
Why?
| | Survival Analysis | 1 | 2008 | 1267 | 0.020 |
Why?
| | Adolescent | 2 | 2017 | 18480 | 0.020 |
Why?
| | United States | 2 | 2013 | 12555 | 0.020 |
Why?
| | Genetic Variation | 1 | 2008 | 926 | 0.010 |
Why?
| | Communication | 1 | 2008 | 761 | 0.010 |
Why?
| | Young Adult | 1 | 2017 | 10793 | 0.010 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2008 | 2062 | 0.010 |
Why?
| | Biomarkers | 1 | 2008 | 3588 | 0.010 |
Why?
|
|
Sankoff's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|